What is the appropriate oral naltrexone dosing schedule for an adult patient?

Oral Naltrexone Dosing for Adults

The standard oral naltrexone dose is 50 mg once daily for both alcohol use disorder and opioid use disorder, with alternative supervised dosing schedules of 100 mg on Mondays and Wednesdays plus 150 mg on Fridays, or 100 mg every other day. 1

Standard Dosing Regimens

For Opioid Use Disorder

• Initiate with 25 mg as a test dose to assess for precipitated withdrawal 1
• If no withdrawal signs occur after the 25 mg test dose, advance to 50 mg daily the following day 1
• This 50 mg daily dose provides adequate blockade of parenterally administered opioids for 24 hours 1

For Alcohol Use Disorder

• 50 mg once daily is the recommended dose 1
• This dosing was validated in placebo-controlled trials demonstrating efficacy over 12 weeks 1
• No test dose is required for alcohol use disorder, though patients must still be opioid-free 1

Alternative Supervised Dosing Schedules

For patients requiring supervised administration, flexible dosing schedules are acceptable: 2, 1

• 100 mg on Mondays and Wednesdays, 150 mg on Fridays (total 350 mg/week) 2
• 100 mg every other day 1
• 150 mg every third day 1

Critical Caveat on Extended Dosing

Higher single doses above 50 mg carry increased risk of hepatocellular injury, so the benefits of extended dosing intervals must be weighed against hepatotoxicity risks 1. The degree of opioid blockade may also be reduced with extended intervals 1.

Mandatory Opioid-Free Period

Patients must be completely opioid-free for 7-10 days minimum before initiating naltrexone to avoid precipitated withdrawal 1. This applies to:

• Short-acting opioids: minimum 7-10 days opioid-free 1
• Buprenorphine or methadone: patients may be vulnerable to precipitated withdrawal for up to 2 weeks 1
• Tramadol must also be discontinued 1

Naloxone Challenge Test

If there is any question of occult opioid dependence, perform a naloxone challenge test before initiating naltrexone: 1

Intravenous route:

• Inject 0.2 mg naloxone IV, observe 30 seconds 1
• If no withdrawal, inject 0.6 mg naloxone, observe 20 minutes 1

Subcutaneous route:

• Administer 0.8 mg naloxone SC, observe 20 minutes 1

If any withdrawal signs appear (nausea, vomiting, sweating, pupillary dilation, muscle aches, anxiety), the test is positive—do NOT start naltrexone and repeat challenge in 24 hours 1.

Monitoring Requirements

Obtain baseline liver function tests and repeat every 3-6 months, as naltrexone has been associated with hepatic injury at supratherapeutic doses 2.

Low-Dose Naltrexone (Off-Label)

For chronic pain conditions, low-dose naltrexone (1-5 mg daily) is used off-label and requires compounding 3, 4, 5. The effective dose is highly individualized, ranging from 0.1-4.5 mg daily, and requires titration to determine the maximally effective dose for each patient 3. This is distinct from standard addiction treatment dosing.

Essential Treatment Context

Naltrexone is only effective as part of comprehensive addiction treatment including psychosocial support, behavioral therapy, and compliance-enhancing measures 1. Medication compliance is critical, as naltrexone alone does not cure dependence 6.